Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2021-07-15 00:00:00 ET · period of report 2021-07-13 · accession 0001209191-21-046788 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-15 | 2021-04-30 | HRTX | Peraza Lisa | VP, CAO | J - Other | $13.90 | +1,530 | 13.5K | +13% | +$21.3K |
| D | 2021-07-15 | 2021-07-13 | HRTX | Peraza Lisa | VP, CAO | F - Tax | $13.48 | -191 | 13.8K | -1% | -$2,575 |
| D | 2021-07-15 | 2021-07-13 | HRTX | Peraza Lisa | VP, CAO | M - OptEx | — | +552 | 14.0K | +4% | — |
| D | 2021-07-15 | 2021-07-13 | HRTX | Peraza Lisa | VP, CAO | M - OptEx | $0.00 | -552 | 7,177 | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-04-30 | J | A | 1,530 | $13.90 | 13,475 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-13 | F | D | 191 | $13.48 | 13,836 | D | — | — | (F3) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. |
| 3 | Common | Common Stock | 2021-07-13 | M | A | 552 | — | 14,027 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Derivative | Restricted Stock Units | 2021-07-13 | M | D | 552 | $0.00 | 7,177 | D | — · — to — | 552 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest in 16 equal quarterly installments beginning three months after the date of grant (10/13/2020). |